Disaggregation of Islet Amyloid Polypeptide Fibrils as a Potential Anti-Fibrillation Mechanism of Tetrapeptide TNGQ.
Abioye RO, Okagu OD, Udenigwe CC.
Int J Mol Sci. 2022 Feb 10;23(4):1972. doi: 10.3390/ijms23041972.
Cardiac gap junctions and connexins: their role in atrial fibrillation and potential as therapeutic targets.
van der Velden HM, Jongsma HJ.
Cardiovasc Res. 2002 May;54(2):270-9. doi: 10.1016/s0008-6363(01)00557-0.
Evaluating the inhibitory potential of natural compound luteolin on human lysozyme fibrillation.
Ali SM, Nabi F, Hisamuddin M, Rizvi I, Ahmad A, Hassan MN, Paul P, Chaari A, Khan RH.
Int J Biol Macromol. 2023 Apr 1;233:123623. doi: 10.1016/j.ijbiomac.2023.123623. Epub 2023 Feb 10.
Inhibition of Islet Amyloid Polypeptide Fibrillation by Structurally Diverse Phenolic Compounds and Fibril Disaggregation Potential of Rutin and Quercetin.
Abioye RO, Okagu OD, Udenigwe CC.
J Agric Food Chem. 2022 Jan 12;70(1):392-402. doi: 10.1021/acs.jafc.1c06918. Epub 2021 Dec 29.
Atrial Fibrillation: The Science behind Its Defiance.
Czick ME, Shapter CL, Silverman DI.
Aging Dis. 2016 Oct 1;7(5):635-656. doi: 10.14336/AD.2016.0211. eCollection 2016 Oct.
Modulation of the Fibrillation Kinetics and Morphology of a Therapeutic Peptide by Cucurbit[7]uril.
Martinez Morales M, van der Walle CF, Derrick JP.
Mol Pharm. 2023 Jul 3;20(7):3559-3569. doi: 10.1021/acs.molpharmaceut.3c00185. Epub 2023 Jun 16.
Adenosine and Adenosine Receptors: Advances in Atrial Fibrillation.
Maille B, Lalevée N, Marlinge M, Vahdat J, Mottola G, Degioanni C, De Maria L, Klein V, Thuny F, Franceschi F, Deharo JC, Guieu R, Fromonot J.
Biomedicines. 2022 Nov 17;10(11):2963. doi: 10.3390/biomedicines10112963.
Atrial Fibrillation, Thromboembolic Risk, and Anticoagulation in Cardiac Amyloidosis: A Review.
Bukhari S, Khan SZ, Bashir Z.
J Card Fail. 2023 Jan;29(1):76-86. doi: 10.1016/j.cardfail.2022.08.008. Epub 2022 Sep 17.
TiO2 Nanoparticles as Potential Promoting Agents of Fibrillation of alpha-Synuclein, a Parkinson's Disease-Related Protein.
Mohammadi S, Nikkhah M.
Iran J Biotechnol. 2017 Aug 19;15(2):87-94. doi: 10.15171/ijb.1519. eCollection 2017.
Identification of potential aggregation hotspots on Abeta42 fibrils blocked by the anti-amyloid chaperone-like BRICHOS domain.
Kumar R, Le Marchand T, Adam L, Bobrovs R, Chen G, Fridmanis J, Kronqvist N, Biverstål H, Jaudzems K, Johansson J, Pintacuda G, Abelein A.
Nat Commun. 2024 Feb 1;15(1):965. doi: 10.1038/s41467-024-45192-4.
